Avantra is now Courtagen Life Sciences

NewsGuard 100/100 Score
Editorial Checklist Reviewed
Aug 30 2011Courtagen Life Sciences, Inc.

Avantra Biosciences Corporation today announced that effective immediately it is changing its name to Courtagen Life Sciences, Inc.  The company will continue to use the Avantra name for their proteomics portfolio, which includes the Avantra Biomarker System.  The Avantra Biomarker System offers users rapid, easy-to-use, quantitative multiplex protein assays using catalog or custom reagents.

Brian McKernan, CEO of Courtagen Life Sciences explained, "The name change reflects the Company's new strategic focus on developing advanced technologies in both genomic and proteomic areas and our commitment to bring additional needed technologies to the market."

Source:

Courtagen Life Sciences, Inc.

Posted in: Business / Finance

Tags: , , , , ,

Comments (0)

Suggested Reading

No consistent pattern found in health responses to blueberry interventions, study shows
The association between handgrip strength and functional outcomes in long COVID-19
Vitamin D receptor presence in breast cancer tumors linked to better survival outcomes
Study reveals breakthrough in non-invasive detection of endometrial cancer
Towards better diagnosis of neurodegenerative disorders: Skin biopsy for α-synuclein detection proves effective
Study reveals e-cigarette users with limited smoking history show similar DNA alterations as smokers
A plant-based diet and its relationship with oxidative biomarkers in footballers
SCIEX’s Jose Castro-Perez Reveals How They're Setting New Standards in Mass Spectrometry

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
New study defines clinical phenotype of Post-infectious ME/CFS, highlighting unique biomarker insights